Ken Griffin Tenaya Therapeutics, Inc. Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$1.93 - $3.99 $386 - $798	-200 Reduced 33.33%	400 $0
Q2 2024 Aug 14, 2024	SELL	$2.72 - $4.99 $1,360 - $2,495	-500 Reduced 45.45%	600 $1,000
Q1 2024 May 15, 2024	BUY	$2.88 - $6.8 $3,168 - $7,480	1,100 New	1,100 $5,000
Q3 2023 Nov 14, 2023	SELL	$2.55 - $5.65 $11,475 - $25,425	-4,500 Reduced 86.54%	700 $1,000
Q2 2023 Aug 14, 2023	SELL	$2.64 - $7.64 $30,624 - $88,624	-11,600 Reduced 69.05%	5,200 $30,000
Q1 2023 May 15, 2023	SELL	$1.92 - $3.59 $37,056 - $69,287	-19,300 Reduced 53.46%	16,800 $47,000
Q4 2022 Feb 14, 2023	BUY	$1.68 - $3.19 $20,160 - $38,280	12,000 Added 49.79%	36,100 $72,000
Q3 2022 Nov 14, 2022	BUY	$2.9 - $5.88 $69,890 - $141,708	24,100 New	24,100 $70,000

56.3M

900

400

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $91.8M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.